Mid/Long Term ECG Monitoring System for Health Professionals - Health Care
FromNuubo
Nuubo considers that cutting edge technology can only be considered as such if it also works in real life, with real patients living a normal life. That is why Nuubo is strongly focused on clinical research. Apart from the completed and published studies, Nuubo currently has approximately 3500 patients enrolled in ongoing clinical trials, validating the Nuubo technology for real clinical use. Nuubo is conducting studies in the following areas:
Most popular related searches
cardiac rehabilitation
atrial fibrillation
atrial fibrilation
clinical trial
clinical study
vein ablation
ECG monitor
pulmonary vein
patient enrollment
patient monitoring
clinical validation
electrocardiogram
health system
- Technology validation
- Risk stratification
- Auricular Fibrillation
- QT analysis
- Cardiac Rehabilitation
The main focus of Nuubo research is Atrial Fibrillation: currently more than 2200 patients are being included in research in three areas of atrial fibrillation: After suffering an ictus of unknown origin, after undergoing pulmonary vein ablation and for screening of patients with risk of AF.
- Technology validation
- Arrhytmia risk stratification
- AF detection after stroke of unknown origin
- AF following ablation
- Sports arrhythmias
- Wearcare – cardiac rehabilitation
Stay in the loop!
Select your areas of interest to receive industry updates.